BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GHIT Fund Commits USD 4.6 Million to Tackle TB and Neglected Diseases in Low- and Middle-Income Regions

The Global Health Innovative Technology (GHIT) Fund announced an investment of approximately JPY 679 million (USD 4.5 million) for the...

April 23, 2025 | News

ABL Bio and GSK Sign Multi-Program Licensing Deal to Develop Neurodegenerative Therapies Using Grabody-B Platform

ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL...

April 07, 2025 | News

FlocCare Raises US$500K to Scale Preventative Health AI Across Asia and UAE

Singapore-based B2B healthcare AI platform FlocCare Pte. Ltd. has just raised US$500K, with backing from DTVP, SDTA Ventures ...

March 28, 2025 | News

Syneron Bio Enters $3.5B Strategic Collaboration with AstraZeneca to Develop Novel Macrocyclic Peptide Therapies

Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical lead...

March 24, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

Insilico Medicine Secures $110M Series E to Advance AI-Powered Drug Discovery and Clinical Innovations

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully s...

March 14, 2025 | News

SPRIM Global Investments and OneIM Launch $300M Joint Venture to Accelerate Clinical Trial Financing

SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and On...

March 11, 2025 | News

Health2Sync Secures Over $20M in Series C Funding to Drive Global Expansion and AI-Driven Chronic Disease Management

Health2Sync (H2), a leading digital health company specializing in chronic disease management, today announced it has raised over US$20 million in a Series...

March 05, 2025 | News

MojiaBio and A*STAR Partner to Develop SGD 44.8 Million Sustainable Biomanufacturing Technology Platform in Singapore

MojiaBio, a global leader in green chemistry and sustainable biomanufacturing, has announced a strategic partnership with the Agency for Science, Technolog...

March 03, 2025 | News

Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...

February 27, 2025 | News

CARsgen Therapeutics and Zhuhai SB Xinchuang Partner to Advance Allogeneic CAR-T Therapies in China

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...

February 26, 2025 | News

Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...

February 17, 2025 | News

Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders

Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, anno...

February 17, 2025 | News

GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the en...

February 03, 2025 | News

Stay Connected